Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
NEW YORK (Reuters) – Pfizer (NYSE:PFE) on Tuesday appealed a federal judge’s refusal to award the drugmaker $75.2 million from a more than decade-old insider trading settlement involving billionaire Steven A. Cohen’s former hedge fund, SAC Capital Management. The
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
By Ahmed Aboulenein and Amina Niasse WASHINGTON (Reuters) -The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said
Wall Street bankers say merger outlook has already jumped in 2025
By Nupur Anand MIAMI (Reuters) – Wall Street bankers are already upbeat about a revival in mergers and acquisitions this year that will buoy broader investment banking activity. It may take some time for deals to materialize, but buyouts including bank deals